US Stock Market Move | Boston Scientific Corporation (BSX.US) plunges over 15% as its performance guidance for the fiscal year 2026 falls below expectations.
On Wednesday, Boston Scientific (BSX.US) plummeted over 15%, marking the largest intraday drop since March 2020, now trading at $77.80.
On Wednesday, Boston Scientific Corporation (BSX.US) fell over 15%, marking its largest intraday decline since March 2020, now trading at $77.80. On the news front, the company's guidance for the fiscal year 2026 shows an adjusted earnings per share expectation of $3.43-3.49, slightly lower than the analysts' average expectation of $3.47. The full-year revenue is expected to be between $22.181 billion and $22.383 billion, lower than analysts' average expectation of $22.368 billion.
Related Articles

US Stock Market Move | Concept stocks of encrypted currency plummeted, IREN Ltd (IREN.US) fell nearly 11%.

AMD's Q4 financial report shines but cannot hide uncertainties in AI, Wall Street questions the sustainability of growth.

Tianqi Lithium Corporation (09696) plans to issue 65.05 million new H shares and HK$2.6 billion in bonds, with net proceeds exceeding HK$5.8 billion. Trading will resume on February 5th.
US Stock Market Move | Concept stocks of encrypted currency plummeted, IREN Ltd (IREN.US) fell nearly 11%.

AMD's Q4 financial report shines but cannot hide uncertainties in AI, Wall Street questions the sustainability of growth.

Tianqi Lithium Corporation (09696) plans to issue 65.05 million new H shares and HK$2.6 billion in bonds, with net proceeds exceeding HK$5.8 billion. Trading will resume on February 5th.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


